Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LENALIDOMIDE vs LENVATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LENALIDOMIDE vs LENVATINIB: Safety Overview

Metric LENALIDOMIDE LENVATINIB
Total FAERS Reports 349,955 33,766
Deaths Reported 35,942 4,449
Death Rate 10.3% 13.2%
Hospitalizations 86,495 19,975
Average Patient Age 69.9 yrs 65.4 yrs
% Female Patients 50.0% 55.8%
FDA Approval Date Aug 3, 2023 Feb 13, 2015
Manufacturer Padagis US LLC Eisai Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription